Syndax Pharmaceuticals Statistics
Total Valuation
SNDX has a market cap or net worth of $1.77 billion. The enterprise value is $1.19 billion.
| Market Cap | 1.77B |
| Enterprise Value | 1.19B |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, after market close.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SNDX has 84.97 million shares outstanding. The number of shares has increased by 15.82% in one year.
| Shares Outstanding | 84.97M |
| Shares Change (YoY) | +15.82% |
| Shares Change (QoQ) | +3.85% |
| Owned by Insiders (%) | 0.82% |
| Owned by Institutions (%) | 106.65% |
| Float | 84.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.19 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.00, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.00 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,005.54 |
Financial Efficiency
Return on equity (ROE) is -47.90% and return on invested capital (ROIC) is -41.37%.
| Return on Equity (ROE) | -47.90% |
| Return on Assets (ROA) | -44.00% |
| Return on Capital (ROIC) | -41.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.14M |
| Employee Count | 184 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.30% in the last 52 weeks. The beta is 0.98, so SNDX's price volatility has been similar to the market average.
| Beta (1Y) | 0.98 |
| 52-Week Price Change | -2.30% |
| 50-Day Moving Average | 22.68 |
| 200-Day Moving Average | 19.07 |
| Relative Strength Index (RSI) | 39.30 |
| Average Volume (30 Days) | 1,132,646 |
Short Selling Information
The latest short interest is 9.62 million, so 11.32% of the outstanding shares have been sold short.
| Short Interest | 9.62M |
| Short Previous Month | 8.33M |
| Short % of Shares Out | 11.32% |
| Short % of Float | 11.37% |
| Short Ratio (days to cover) | 7.43 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -229.95M |
| Pretax Income | -209.36M |
| Net Income | -209.36M |
| EBITDA | -208.40M |
| EBIT | -209.15M |
| Earnings Per Share (EPS) | -$2.98 |
Balance Sheet
The company has $577.80 million in cash and $1.64 million in debt, giving a net cash position of $576.17 million or $6.78 per share.
| Cash & Cash Equivalents | 577.80M |
| Total Debt | 1.64M |
| Net Cash | 576.17M |
| Net Cash Per Share | $6.78 |
| Equity / Book Value | 554.20M |
| Book Value Per Share | 6.52 |
| Working Capital | 522.78M |
Cash Flow
| Operating Cash Flow | -160.60M |
| Capital Expenditures | n/a |
| Free Cash Flow | -160.60M |
| FCF Per Share | -$2.28 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SNDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.82% |
| Shareholder Yield | -15.82% |
| Earnings Yield | -11.85% |
| FCF Yield | -9.09% |
Analyst Forecast
The average price target for SNDX is $35.00, which is 68.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $35.00 |
| Price Target Difference | 68.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |